Semi-annual Assessment Report on "Corporate Value and Return Enhancement" Action Plan 2025
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Semi-annual Assessment Report on "Corporate Value and Return Enhancement" Action Plan 2025
Filed with SSE · · 4 pages · Chinese
Release
Jiangsu Lianhuan Pharmaceutical Co., Ltd. on 6ix
Earlier from Jiangsu Lianhuan Pharmaceutical
- Announcement on the Change of Disclosure Date for the 2025 Semi-annual Report
- Announcement on Receiving Results of GMP Compliance Inspection Concerning Drugs by the Wholly-owned Subsidiary
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
- Announcement on Holding Subsidiary’s Drug Passing Generic Drug Consistency Evaluation
- Notice on Convening the 1st Extraordinary General Meeting in 2025
Later from Jiangsu Lianhuan Pharmaceutical
- Announcement on Resolutions of the 15th Extraordinary Meeting of the 9th Board of Directors
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
- Announcement on Electing Employee Representative Director
- Announcement on Convening the 2025 Semi-annual Performance Briefing
- Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2025
Follow Jiangsu Lianhuan Pharmaceutical into a list and get an email when it puts out news.
Follow Jiangsu Lianhuan Pharmaceutical